Ernexa Therapeutics Inc.
ERNANasdaqCIK 748592HealthcareFiscal year ends Dec 31
Reports and events: 421 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-1517:25 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-047287 |
| 2026-09-1617:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-042963 |
| 2026-09-1616:50 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001493152-26-042934 |
| 2026-08-0617:31 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001493152-26-036424 |
| 2026-07-0216:40 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-031930 |
| 2026-07-0216:30 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-26-031920 |
| 2026-06-2616:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-030306 |
| 2026-05-1117:09 ET | DEF 14A | Proxy statementPeriod 2026-05-11 | 0001493152-26-022281 |
| 2026-05-1117:02 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001493152-26-022276 |
| 2026-05-0416:10 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-26-021112 |
| 2026-03-2017:00 ET | 8-K | 3.01 Delisting notice | 0001493152-26-011922 |
| 2026-03-1317:22 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001493152-26-010102 |
| 2026-02-2616:31 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-008182 |
| 2026-02-1721:26 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-26-016685 |
| 2026-02-1117:10 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-006227 |
| 2026-02-0509:46 ET | S-1/A | Registration statement, amended | 0001493152-26-005215 |
| 2026-02-0421:59 ET | S-1/A | Registration statement, amended | 0001493152-26-004987 |
| 2026-02-0320:10 ET | S-1 | Registration statement | 0001493152-26-004809 |
| 2025-12-1108:31 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-027167 |
| 2025-11-0716:30 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001493152-25-021287 |
| 2025-08-1316:31 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001493152-25-011910 |
| 2025-07-0716:39 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001641172-25-018009 |
| 2025-06-1216:37 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001641172-25-014877 |
| 2025-06-1120:39 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-25-058646 |
| 2025-06-0916:30 ET | 8-K | 3.02 Unregistered sale of equity; 8.01 Other events | 0001641172-25-014318 |
| 2025-06-0216:30 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001641172-25-013249 |
| 2025-05-0716:30 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001641172-25-009044 |
| 2025-04-1416:45 ET | DEF 14A | Proxy statementPeriod 2024-12-31 | 0001641172-25-004585 |
| 2025-04-0410:55 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-25-032062 |
| 2025-04-0308:55 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.08 Item not in the standard list; 9.01 Financial statements and exhibits | 0001641172-25-002514 |
| 2025-03-2607:30 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001641172-25-000681 |
| 2025-03-2416:30 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001641172-25-000300 |
| 2025-03-1216:20 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001493152-25-010051 |
| 2025-03-1216:15 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001493152-25-010049 |
| 2025-03-0517:55 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001104659-25-020984 |
| 2025-02-1316:30 ET | 8-K | 5.08 Item not in the standard list | 0001493152-25-006446 |
| 2025-01-1016:15 ET | 8-K | 3.01 Delisting notice; 5.02 Departure or appointment of officers or directors | 0001493152-25-001704 |
| 2025-01-0316:15 ET | 8-K | 3.01 Delisting notice | 0001493152-25-000246 |
| 2024-11-1217:16 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001493152-24-044841 |
| 2024-11-0516:30 ET | S-1 | Registration statement | 0001493152-24-043663 |
| 2024-10-2916:30 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-042902 |
| 2024-10-0716:15 ET | DEF 14A | Proxy statementPeriod 2024-10-07 | 0001493152-24-040286 |
| 2024-09-2716:15 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001493152-24-038532 |
| 2024-09-2516:36 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-038129 |
| 2024-09-2316:30 ET | 8-K | 3.01 Delisting notice | 0001493152-24-037815 |
| 2024-08-1917:00 ET | 8-K | 8.01 Other events | 0001493152-24-033119 |
| 2024-08-1316:30 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001493152-24-031639 |
| 2024-05-1417:14 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001140361-24-026010 |
| 2024-03-2216:30 ET | 8-K | 3.01 Delisting notice | 0001140361-24-014809 |
| 2024-03-1807:30 ET | 10-K/A | Annual report, amendedPeriod 2023-12-31 | 0001140361-24-013709 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 14:05 ET. Listed shows no prices and gives no investment advice.